Helmerich & Payne (HP) Gets a Buy from Piper Sandler
Piper Sandler analyst Derek Podhaizer maintained a Buy rating on Helmerich & Payne today and set a price target of $43.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Podhaizer covers the Energy sector, focusing on stocks such as Helmerich & Payne, Cactus, and SLB. According to TipRanks, Podhaizer has an average return of 16.4% and a 59.60% success rate on recommended stocks.
Currently, the analyst consensus on Helmerich & Payne is a Moderate Buy with an average price target of $41.30.
Based on Helmerich & Payne’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $932.36 million and a GAAP net loss of $58.61 million. In comparison, last year the company earned a revenue of $1.02 billion and had a net profit of $1.65 million
Based on the recent corporate insider activity of 57 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of HP in relation to earlier this year. Last month, Michael Lennox, the EVP, WESTERN HEMISPHERE LAND of HP sold 5,000.00 shares for a total of $175,000.00.
Read More on HP:
Disclaimer & DisclosureReport an Issue
- Helmerich & Payne reports Q3 adjusted EPS (11c), consensus 10c
- Helmerich & Payne sees FY26 gross CapEx $270M-$310M
- HP Earnings this Week: How Will it Perform?
- Insiders Cash Out at Immunovant, Helmerich & Payne, SharkNinja, PBF Energy, Venture Global
- Helmerich & Payne price target lowered to $36 from $39 at Morgan Stanley
